Out on a high

1 Aug 2005 By Robert Cyran

It may sound defeatist for the pharma group s new boss to flog the company. It isn t. Pharma acquisitions may have a chequered history, but the economic case for the sale of Astra is overwhelming.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)